rs4295
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000789.4(ACE):c.418-70C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.623 in 1,362,354 control chromosomes in the GnomAD database, including 265,119 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.62 ( 28807 hom., cov: 31)
Exomes 𝑓: 0.62 ( 236312 hom. )
Consequence
ACE
NM_000789.4 intron
NM_000789.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.498
Publications
50 publications found
Genes affected
ACE (HGNC:2707): (angiotensin I converting enzyme) This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020]
ACE Gene-Disease associations (from GenCC):
- renal tubular dysgenesis of genetic originInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- intracerebral hemorrhageInheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 17-63478937-C-G is Benign according to our data. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-63478937-C-G is described in CliVar as Benign. Clinvar id is 1273999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.656 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACE | NM_000789.4 | c.418-70C>G | intron_variant | Intron 2 of 24 | ENST00000290866.10 | NP_000780.1 | ||
ACE | NM_001382700.1 | c.182+839C>G | intron_variant | Intron 2 of 21 | NP_001369629.1 | |||
ACE | NM_001382701.1 | c.-198+839C>G | intron_variant | Intron 2 of 22 | NP_001369630.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.615 AC: 93385AN: 151798Hom.: 28773 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
93385
AN:
151798
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.624 AC: 755668AN: 1210438Hom.: 236312 Cov.: 17 AF XY: 0.623 AC XY: 379444AN XY: 609270 show subpopulations
GnomAD4 exome
AF:
AC:
755668
AN:
1210438
Hom.:
Cov.:
17
AF XY:
AC XY:
379444
AN XY:
609270
show subpopulations
African (AFR)
AF:
AC:
16194
AN:
27754
American (AMR)
AF:
AC:
27382
AN:
38778
Ashkenazi Jewish (ASJ)
AF:
AC:
13073
AN:
24086
East Asian (EAS)
AF:
AC:
22668
AN:
35600
South Asian (SAS)
AF:
AC:
48013
AN:
76706
European-Finnish (FIN)
AF:
AC:
30029
AN:
48422
Middle Eastern (MID)
AF:
AC:
3067
AN:
5320
European-Non Finnish (NFE)
AF:
AC:
562926
AN:
901658
Other (OTH)
AF:
AC:
32316
AN:
52114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
15543
31087
46630
62174
77717
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
14060
28120
42180
56240
70300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.615 AC: 93469AN: 151916Hom.: 28807 Cov.: 31 AF XY: 0.616 AC XY: 45739AN XY: 74240 show subpopulations
GnomAD4 genome
AF:
AC:
93469
AN:
151916
Hom.:
Cov.:
31
AF XY:
AC XY:
45739
AN XY:
74240
show subpopulations
African (AFR)
AF:
AC:
24449
AN:
41434
American (AMR)
AF:
AC:
10186
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
1921
AN:
3464
East Asian (EAS)
AF:
AC:
3323
AN:
5146
South Asian (SAS)
AF:
AC:
3004
AN:
4792
European-Finnish (FIN)
AF:
AC:
6493
AN:
10556
Middle Eastern (MID)
AF:
AC:
156
AN:
294
European-Non Finnish (NFE)
AF:
AC:
42148
AN:
67930
Other (OTH)
AF:
AC:
1266
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1863
3725
5588
7450
9313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
770
1540
2310
3080
3850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2235
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.